Literature DB >> 14736501

SUMO, a ubiquitin-like modifier implicated in neurodegeneration.

Andrew P Lieberman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14736501     DOI： 10.1016/j.expneurol.2003.10.009

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  4 in total

1.  Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2.

Authors:  Emily Foran; Alexey Bogush; Michael Goffredo; Paola Roncaglia; Stefano Gustincich; Piera Pasinelli; Davide Trotti
Journal:  Glia       Date:  2011-07-18       Impact factor: 7.452

2.  Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation.

Authors:  Sarmistha Mukherjee; Monzy Thomas; Nahid Dadgar; Andrew P Lieberman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

3.  Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration.

Authors:  Jiang Fu; H-M Ivy Yu; Shang-Yi Chiu; Anthony J Mirando; Eri O Maruyama; Jr-Gang Cheng; Wei Hsu
Journal:  PLoS Genet       Date:  2014-10-09       Impact factor: 5.917

4.  Characterization of a new SUMO-1 nuclear body (SNB) enriched in pCREB, CBP, c-Jun in neuron-like UR61 cells.

Authors:  Joaquín Navascués; Rocio Bengoechea; Olga Tapia; José P Vaqué; Miguel Lafarga; Maria T Berciano
Journal:  Chromosoma       Date:  2007-05-26       Impact factor: 2.919
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.